What Do Stool (Poop) Color Changes and Warning Signs Mean
GLP-1RA Reward Behaviour Systematic Review (PubMed, 2024) GLP-1 Receptor Signalling in Reward Circuitry, Dopamine, and Addiction Research A systematic review of GLP-1 receptor agonist effects on reward behaviour published on PubMed following PRISMA guidelines across OVID, PubMed, Scopus, and Google Scholar evaluated the evidence for GLP-1Rs role in reward dysfunction across obesity, type 2 diabetes, and psychiatric conditions
Specific considerations for autoimmune disease patients: Delayed gastric emptying may affect absorption of oral medications, including some immunosuppressants Monitoring challenges in distinguishing disease activity from medication side effects Importance of maintaining stable immunosuppression regimens Patients should seek immediate medical attention for severe, persistent abdominal pain (potential pancreatitis or gallbladder disease), vision changes, severe vomiting/dehydration, neck mass/hoarseness, or allergic reactions
Should patients on GLP-1 drugs have lab work monitored